JILL RICE: Open Payments
NPI 1093823361 · HAMBURG, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,233 in 32 payments from 4 companies in 2025. Trend: 2023 $514 · 2024 $592 · 2025 $1,233
Food & beverage: $1,017Education: $216
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 26 | $867 |
| Neurocrine BioSciences, Inc. | 3 | $188 |
| ACADIA Pharmaceuticals Inc | 2 | $150 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
Products named: AUSTEDO XR, INGREZZA, NUPLAZID, REXULTI.
Industry payments across NY — which companies pay providers there.
